AVITA Medical (ASX:AVH) FFO


ASX:AVH AVITA Medical Inc ASX:AVH
57 GF Score
Price A$1.09
GF Value A$3.05
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is AVITA Medical FFO?

FFO (Funds from operations) only applies to REITs.

ASX:AVH
57GF Score
AVITA Medical Inc ASX:AVH
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AVITA Medical (ASX:AVH) Overvalued in 2026?

Based on GuruFocus' analysis, AVITA Medical stock appears to be undervalued. The current stock price of A$1.09 is trading 64.4% below its estimated GF Value™ of A$3.05. GuruFocus considers AVITA Medical to be Possible Value Trap.

Key valuation signals for ASX:AVH:

  • FFO:
  • GF Value™: A$3.05 vs. price of A$1.09 (64.4% below fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the ASX:AVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AVITA Medical Business Description

Address 28159 Avenue Stanford, Suite 220, Valencia, Santa Clarita, CA, USA, 91355
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
57GF Score

Get the complete analysis for ASX:AVH

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.09
Price
A$3.05
GF Value